Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label
The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn of NAION, a rare cause of sudden vision loss. Here…
The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn of NAION, a rare cause of sudden vision loss. Here…
A CDSCO expert panel recommended a Phase I trial of Indian Immunologicals' live attenuated Zika vaccine, developed with Griffith University and funded by ICMR.
PMV Pharmaceuticals' rezatapopt produced a 48% response rate in platinum-resistant ovarian cancer with TP53 Y220C in the pivotal PYNNACLE trial, with an FDA filing planned…
Mayo Clinic data from ObesityWeek 2026 show GLP-1 users with weakened hearts saw greater one-year gains in heart structure and function than matched non-users, with…
Up to 15 people have died and more than 300 have sought care in Imphal after drinking spurious liquor in Manipur's Chandel district. What we…
The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn…
Testosterone prescriptions for women jumped 146% since 2023, but with no FDA-approved product for women, patients and doctors report a growing wave of pharmacy denials, dosing workarounds, high compounding costs,…
UN and WHO officials say the DR Congo Ebola outbreak, now the deadliest in the country's history with over 7,250 cases and 3,500 deaths, is improving in some regions but…
Pennsylvania has confirmed two more measles-associated deaths, bringing the state's 2026 total to four, as nearly 700 cases and 133 hospitalizations mark its worst measles outbreak in more than three…
China's NMPA has approved its third BCI medical device standard, the world's first product guideline for AI-powered brain-computer interfaces, setting unified rules for brainwave data collection, processing, and storage ahead…
Tempus AI CEO Eric Lefkofsky told CNBC healthcare will likely be AI's biggest beneficiary, pointing to $1.5 trillion in wasted US healthcare spending and Tempus's own AI-driven genomics and cancer…
WHO Director-General Tedros Adhanom Ghebreyesus praised India's primary healthcare expansion, ASHA workers, and efforts to strengthen medical product regulation during a meeting with Health Minister JP Nadda in Timor-Leste.
South Korea's foreign patient numbers jumped 71.7% to 2.01 million in 2025, as travelers increasingly add affordable, efficient health screenings to their trips. Here's how Korea is rising as a…
Novo Holdings has taken a minority stake in Huizhou ForYou Medical, a China-based wound care CDMO, betting on structural growth in advanced wound care manufacturing as chronic wound cases and…
WHO has prequalified a multi-dose vial of the maternal RSV vaccine RSVpreF, unlocking affordable, large-scale rollout in lower-income countries and clearing a Gavi-backed programme to protect infants from a leading…
New research shows the global AI in healthcare market growing from USD 41.84 billion in 2025 to USD 1,136.90 billion by 2035 at a 39.1% CAGR, led by generative AI,…